Published in Haematologia (Budap) on January 01, 1976
A stop-codon mutation in the BRI gene associated with familial British dementia. Nature (1999) 2.46
Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol (1999) 1.93
[Fulminating pneumococcal septicemia in a 2 year old child with sickle cell anemia]. Ned Tijdschr Geneeskd (2003) 1.88
Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia (2001) 1.84
Ligand-induced redistribution of lymphocyte membrane ganglioside GM1. Nature (1975) 1.57
Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet (2001) 1.53
SIOP Working Committee on Psychosocial issues in pediatric oncology: guidelines for care of long-term survivors. Med Pediatr Oncol (1996) 1.42
Polymorphic DNA haplotypes at the phenylalanine hydroxylase (PAH) locus in European families with phenylketonuria (PKU). Am J Hum Genet (1989) 1.41
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain (1990) 1.19
Familial occurrence of congenital malformations and ring chromosome (46,XX,Cr). J Med Genet (1970) 1.19
The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia. Cancer (1985) 1.18
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11
[Splenectomy in children; indications and surgical aspects]. Ned Tijdschr Geneeskd (2003) 1.09
Effect of interferon-alpha 1 from E. coli on some cell functions. Science (1980) 1.08
Human recombinant granulocyte-macrophage colony-stimulating factor in pediatric oncology practice. Pediatr Hematol Oncol (1994) 1.08
CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes. Clin Genet (2006) 1.07
Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol (1984) 1.05
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer (1996) 1.04
Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group. Bone Marrow Transplant (2003) 1.04
Morphological diagnosis in childhood leukaemia. Br J Haematol (1978) 1.01
Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation. Leukemia (2010) 1.00
T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis. Cancer Res (1981) 1.00
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients. J Clin Immunol (1984) 0.96
Christmas disease in one of a pair of monozygotic twin girls, possibly the effect of lyonization. J Med Genet (1972) 0.96
Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiatry (1991) 0.96
Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family. Gene (2001) 0.95
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia (2013) 0.94
[Current methods for study of human chromosomes]. Orv Hetil (1965) 0.94
'Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesis. Am J Surg Pathol (2000) 0.94
Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor. Cell Immunol (1981) 0.93
Diffuse calcinosis cutis in a patient with congenital leukemia and leukemia cutis. Dermatology (2000) 0.93
Granular cell change in astrocytic tumors. Am J Surg Pathol (1996) 0.92
The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92
Psychosocial problems in families of a child with cancer. Med Pediatr Oncol (1985) 0.91
Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13. Ann N Y Acad Sci (2000) 0.90
Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol (1998) 0.90
Familial cerebral amyloid angiopathy related to stroke and dementia. Amyloid (2001) 0.90
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia (2005) 0.89
Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somat Cell Mol Genet (1990) 0.89
Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. J Gen Virol (1988) 0.89
Hemihypertrophy: 10 years follow-up and chromosomal study. Acta Paediatr Acad Sci Hung (1965) 0.88
Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction. Eur J Immunol (1987) 0.87
Interferon suppresses antigen- and mitogen-induced leukocyte migration inhibition. Nature (1980) 0.87
EGNA-specific LIF production of human lymphocyte subsets. Cell Immunol (1984) 0.87
Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Proc Natl Acad Sci U S A (1984) 0.87
Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Cancer Res (1981) 0.87
Development of a (32)P-postlabeling method for the detection of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in vivo. Chem Res Toxicol (2000) 0.86
Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol (2011) 0.85
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies. Clin Immunol Immunopathol (1982) 0.84
Study of the role of Chlamydia, Mycoplasma, Ureaplasma and other microaerophilic and aerobic bacteria in uterine infections of mares with reproductive disorders. Acta Vet Hung (2003) 0.83
The bifactor model of the Maslach Burnout Inventory-Human Services Survey (MBI-HSS)--an alternative measurement model of burnout. Stress Health (2013) 0.83
Psychological late effects of leukemia in children and their prevention. Med Pediatr Oncol (1981) 0.83
Thyroid autoantibodies and satellite associations in Down's syndrome. Hum Hered (1970) 0.83
Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection. J Virol (1986) 0.83
Coping with cadmium exposure in various ways: the two helicid snails Helix pomatia and Cantareus aspersus share the metal transcription factor-2, but differ in promoter organization and transcription of their Cd-metallothionein genes. J Exp Zool A Ecol Genet Physiol (2009) 0.83
Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein. J Neurol Sci (1995) 0.83
Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. Br J Haematol (2000) 0.83
Cellular and humoral immune responses to synthetic peptides deduced from the amino-acid sequences of Epstein-Barr virus-encoded proteins in EBV-transformed cells. Int J Cancer (1987) 0.82
Migration inhibition caused by EBV-specific 48K subcomponent of EBNA and the associated 53K cellular protein. Int J Cancer (1982) 0.81
A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors. Lymphokine Res (1986) 0.81
Leukaemia in children with Down's syndrome. Oncology (1983) 0.81
Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. IARC Sci Publ (1999) 0.81
Nitric oxide and ATP co-mediate the NANC relaxant response in the guinea-pig taenia caeci. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.80
Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (2001) 0.80
Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts. Allergy (1980) 0.80
Phytohaemagglutinin-induced leukocyte migration inhibition and phytohaemagglutinin skin test for screening the cell-mediated immune response in children. Allergy (1980) 0.80
Progressive vaccinia: immunological aspects and transfer factor therapy. Infection (1978) 0.80
Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers. Cancer Res (1981) 0.80
Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia. Br J Haematol (2001) 0.80
The inhibitory effect of leukaemia associated antigen and leukaemic serum on the leukocyte migration of children with acute leukaemia in remission. Acta Allergol (1974) 0.80
Chromosomal peculiarities and "in vitro" examinations in Fanconi's anaemia. Humangenetik (1969) 0.80
Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors. J Immunol (1981) 0.80
Immunological and virological investigations in Down's syndrome. Eur J Pediatr (1982) 0.79
Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. Cancer Res (1984) 0.79
The effect of synthetic peptides corresponding to Fc sequences in human IgG1 on various steps in the B cell activation pathway. Eur J Immunol (1988) 0.79
No clastogenic activity of a senna extract in the mouse micronucleus assay. Mutat Res (1999) 0.79
Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits. Bone Marrow Transplant (2003) 0.79
A newly formed amyloidogenic fragment due to a stop codon mutation causes familial British dementia. Ann N Y Acad Sci (2000) 0.79
Cell-mediated immune response in patients with Down's syndrome. Acta Paediatr Acad Sci Hung (1974) 0.79
[Neurologic complications of childhood malignancies]. Orv Hetil (1994) 0.79
Lymphoblastic transformation, chromosome pattern and delayed-type skin reaction in ataxia telangiectasia. Acta Paediatr Scand (1971) 0.79
[Pituitary function and growth in children under treatment for leukemia (author's transl)]. Monatsschr Kinderheilkd (1980) 0.79
Chromosome 13 dementia syndromes as models of neurodegeneration. Amyloid (2001) 0.78
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma. Haematologia (Budap) (1976) 0.78